A liver stiffness score puts a number on how much scar tissue the liver has laid down: the reference version is an elastography scan on a clinic machine, and the practical version is a blood-based stand-in calculated from body weight, fasting glucose, AST, platelets and albumin. Fibrosis is silent for years, so the number is worth having early. Neither route is a home measurement: one needs a scanner and an operator, the other a venous draw. For the definition rather than the method, see Liver stiffness.
What you need
For the measured value you need the equipment: transient elastography (FibroScan) or shear-wave elastography on an ultrasound machine, booked through a hepatology or radiology service. It is painless, takes about ten minutes, and asks you to fast for two to three hours beforehand, since eating raises the reading.
For the blood-based estimate, one fasting draw and a scale:
- Body weight in kilograms.
- Fasting glucose in mmol/L; a US result in mg/dL divided by 18 gives the same value.
- AST (aspartate aminotransferase) in U/L, from a liver panel.
- Platelet count from a complete blood count, in 109 per liter (thousands per microliter on US reports).
- Albumin in g/L, so a US 4.2 g/dL is 42 g/L.
- The race or ethnicity category the model asks for: White, Hispanic, Asian or Black.
How the measurement works
Elastography measures a physical property directly: the probe sends a mechanical pulse into the liver and times the shear wave it creates. Stiffer, scarred tissue carries the wave faster, and the machine converts that speed into kilopascals, taking the median of about ten readings.
The blood-based score never touches the liver; it reads the consequences of scarring, each input pushing the result in a known direction. Higher AST raises it, because damaged cells leak the enzyme. Lower platelets raise it, since advancing fibrosis restricts flow through the liver and the enlarging spleen holds platelets back. Lower albumin raises it, because a scarred liver synthesizes less protein. Higher weight and glucose raise it, standing in for the metabolic disease behind most fibrosis today; this calculator treats a glucose of 7.0 mmol/L or more as diabetes. Six weighted inputs are not work to do by hand, so put your values into the Liver Stiffness Score (LSS) and let it do the arithmetic.
How to read the result
The calculator returns a number plus probabilities for fibrosis at stage F2 or above, F3 or above, and F4, on four bands:
| Score | What it reports |
|---|---|
| Below 3 | Fibrosis unlikely |
| 3 to 7 | Intermediate zone, interpret cautiously |
| 7 to 10 | Fibrosis of stage F2 or higher is possible |
| Above 10 | Fibrosis of stage F2 or higher is likely |
Those are likelihoods, not stages, and the intermediate band is uninformative rather than reassuring. They work in sequence: the first-line FIB-4 Fibrosis Index clears the low-risk majority, and everything above it goes on to elastography.
Kilopascal thresholds are specific to the device and to the cause of disease. As rough orientation in fatty liver disease, guidance treats a value under about 8 kPa as low risk for advanced fibrosis and one above roughly 12 kPa as high risk, with an unresolved band between; viral and alcohol-related disease use different numbers, and an unreliable scan should be repeated.
What it does not tell you
Stiffness is not the same thing as scarring. A liver can be stiff from congestion in heart failure, a hepatitis flare, bile duct obstruction, or a recent meal. Each raises kilopascals with no fibrosis present, so a high reading is a question, not a verdict.
The blood-based version also inherits the weaknesses of its inputs: platelets fall for hematological and drug-related reasons unconnected to the liver, albumin drops in inflammation and undernutrition, and AST rises after hard exercise or a heavy drinking week.
Neither names a cause: alcohol-related, metabolic, viral and autoimmune disease look alike here, and neither detects the inflammation of steatohepatitis, which turns quiet fat into progressing scar. A model carrying a race term is anchored to the cohort it was fitted in; scans read poorly with obesity or ascites unless the larger probe is used; neither is established for children or in pregnancy. Both classify you at one moment; neither can show that a diet reversed anything.
Related reading
- Steatohepatosis
- Albumin
- Which Blood Tests Reflect Aging and How to Read Them
- How to Improve Metabolic Health: A Practical Guide
Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.